3rd Edition of International Heart Congress | June 05-07, 2025 | Rome, Italy

Hypertrophic cardiomyopathy (HCM) is one of the most common heart diseases and a leading cause of sudden cardiac death, which posed a serious threat to human life. HCM is caused by various factors, which eventually results in myocardial dysfunction and heart failure. Although studies on HCM have been documented well, the molecular mechanism of HCM remains to be explored. Recent studies have shown the discovery of some new biomarkers of HCM and identification of its signaling pathways. It has revealed significant and promising progress in the research of HCM molecular signaling and mechanism. With the introduction of new ideas and the application of new technologies in cardiomyopathy research, there is hope for a qualitative leap in the diagnosis and treatment of cardiomyopathy in the near future.

3rd Edition of International Heart Congress | Rome, Italy | June 05-07, 2025

Dear Congress Visitors:

As the Congress Organizing Committee Member, Keynote Speaker and Session Chair, I am very honored and pleased to write these welcome notes. 
The current congress, Heart Congress 2025, focuses to address "Heart Health in Focus: Bridging Science, Innovation, and Patient Care", to bring leading researchers, scientists, clinicians, and industry professionals together from cardiovascular health and disease fields around the world. The congress will include outstanding keynote sessions, plenary lectures, invited speeches, research presentations, technical demonstrations, and panel discussions around the world.

Heart Congress 2025 covers a comprehensive spectrum of topics ranging from Cardiovascular Diseases to Cardiovascular Engineering and Technology. This congress embraces diverse aspects such as Pediatric and Congenital Cardiovascular Disease, Cardio-Oncology, Geriatric Cardiology and many more. All the planned cutting-edge presentations and demonstrations provide deep insights into molecular and cellular cardiology and lipidology, transcend traditional boundaries, and encompass cutting-edge subjects from Arteriosclerosis to Stem Cell Research and Regeneration in Cardiology.

I am very excited to look forward to meeting with you at this upcoming fantastic congress.

3rd Edition of International Heart Congress

This third congress undoubtedly promises a lot of important and innovative information in the field of Cardiology, undoubtedly to face the serious problems of management and treatment with the impact of various pathologies such as coronaré heart disease or heart failure in an increasingly elderly population with a higher incidence of heart failure All these and other topics will be discussed in order to improve the lives of patients and make more effort to work in the various areas.

Heart Congress 2025 | June 05-07, 2025

It Is a pleasure to welcome you to this important scientific event entitled “International Heart Congress-Rome 2025 - Heart Health in Focus: Bridging Science, Innovation, and Patient Care”.

Cardiovascular events continue to represent a major cause of global mortality, among them heart failure and its complications. In patients with Heart Failure, mortality is still very high–approximating 50 % over 5 years–which means that this syndrome is meanwhile deadlier than many cancer types.

It will be an important aspect of this congress to bring together experts from the fields of basic research, translational medicine, pharma R&D, and patient care in order to help improve cardiovascular outcomes.

I renew the welcome to all of you and wish you all the best in your work.

3rd Edition of International Heart Congress | Hybrid Event

I am delighted to extend a warm welcome to this year's Heart Congress 2025 at Rome, Italy.

As we gather to explore the latest advances in cardiac care, I am particularly excited to share insights on the emerging field of Pulse Field Ablation (PFA) for atrial fibrillation.

In my upcoming presentation on "Complications with Pulse Field Ablation for Atrial Fibrillation," we will critically examine both the promises and challenges of this groundbreaking technology. While PFA represents a significant leap forward in AF treatment, understanding its potential complications is crucial for optimal patient outcomes. Especially in times, when more and more complications are emerging with wider use, it assumes significance.

I look forward to engaging in meaningful discussions with you all, sharing experiences, and learning from your perspectives. This conference provides an invaluable opportunity to shape the future of Cardiology through collaborative learning and scientific exchange.

Together, let's advance our understanding of safer and more effective AF treatments.

3rd Edition of International Heart Congress | Rome, Italy

It is my great pleasure to welcome Reputed Faculty/ Delegates from across the Globe to our Forthcoming 15th Cardiomersion Global Workshop at Rome Italy in collaboration with 3rd International Heart Congress. After the highly successful 14th Global conference in India and our previous successful collaborations with Magnus group at Paris (2022) and Tokyo (2023) we are once again looking forward for an overwhelming response from across the Globe.

In the past decade there have been tremendous technological advancements in the Management of Cardiovascular and Thoracic diseases. However more important yet less highlighted, are the unimaginable advancements in the Surgical skills and Team approach which has actually made complex procedures look simpler, more effective in terms of immediate and long term outcomes.

In this Forthcoming Cardiomersion Workshop we are inviting experts from all across the Globe to share their individual experiences as well as knowledge on how the advancing technologies can be best utilized most appropriately for reducing complications and for improving outcomes by appropriate enhancements of skills to make the best utilization of the advancing technologies. Along with this, the most appropriate use of Prevention, Guidelines directed Medical management as well as Rehabilitation will also contribute towards further improving the comprehensive management.

All Cardiologists, Cardiovascular Thoracic Surgeons, Cardiovascular Anesthesiologists, Intensivists, Pulmonologists, Endocrinologists, Nephrologists, Oncologists, Physiotherapists, Dieticians, Physchologists, Nurses, Physician Assistants, Technicians, Healthcare Managers along with any other specialists who deal with Cardiovascular Thoracic as well as other Lifestyle diseases are welcome to actively participate in this workshop so that we can accomplish our goal of improving Cardiovascular Thoracic disease management Globally and reduce the morbidity as well as mortality related to Cardiovascular Thoracic and other Lifestyle diseases, which have now emerged as the leading causes of Death.

Rome is a very beautiful and we also welcome all participants to enjoy the tourist attractions of the city, utilizing this opportunity to improve Lifestyle and to get rid of all your stress which is now emerging as a major Risk factor for precipitating fatal complications at an early age.

Heart Congress 2025 | Rome, Italy

Dear colleagues, dear congress visitors, it is an honor and a pleasure to welcome you to the “3rd International Heart Congress” and to write a few welcome notes, as well. I am confident that you will be in the position to join basic and clinical scientists, healthcare experts, pharmacologists, and cardiologists to discuss and exchange your valuable opinions in regard to various vascular and heart diseases, their non-pharmacological and pharmacological managements, and different diagnostic procedures, thus promoting novel advancements in cardiovascular health. I hope that the forthcoming congress will help you advance your current knowledge and attract our distinguished experts to collaborate with you in the future to set even higher standards in this important scientific and clinical field.

I wholeheartedly welcome you and wish you the very best in your work.

3rd Edition of International Heart Congress | June 05-07, 2025

Dear colleagues!

Welcome to all participants of the 3rd Edition of International Heart Congress (Heart Congress 2025), taking place from June 05-07, 2025, in Rome, Italy. The organizers have designated the dominant theme of this year's conference as "Heart Health in Focus: Bridging Science, Innovation, and Patient Care". This implies that scientific achievements, primarily innovative technologies, should be directed for the benefit of patients with cardiac pathology.

Over the past 30 years, cardiovascular mortality worldwide has decreased by 30%. But in most regions of the world, they occupy a large place in adult mortality. Of course, as a result of the use of innovative technologies and secondary prevention, the situation is improving. But we must use the opportunities of primary prevention at the population level. It is risk factors that play an important role in cardiovascular morbidity. I believe that one of the key factors is also the comorbidity of vascular pathology and somatic diseases. Thus, a personalized approach comes to the forefront in the treatment and prevention of patients with cardiac pathology. The conference program is very interesting and covers different countries of the world. The conference is growing, which means its importance is becoming more and more important.

I wish success to the conference participants.

Heart Congress 2025 | Hybrid Event

Not in the right environment to innovate and commercialize your Heart research? Not feeling appreciated? Move!

Without a doubt, recent advances in heart research including biomaterials, nanotechnology, drugs, diagnosis, prevention, and more have revolutionized cardiovascular medicine over the last several decades. But, where are the products? While some of these wonderful advances have made it to the market helping real patients, many have not. Are we doing enough to translate heart research into real products? Are companies not paying attention to this wonderful research? Are Universities not doing enough to license academic research or start new companies? What about federal funding agencies? Are they supporting the commercialization of heart research? And, most importantly, are you in the right environment to commercialize your heart research?

Well in my own experience, above all else, it takes a supportive environment. It takes a proper mind set to translate lab research into commercial products. It takes determination and fortitude to see it through. You need to surround yourself with the right people–and if you are currently not around a supportive optimistic environment, leave! Leave the University you are at - I did! Leave that company that is stifling your advances-I did! Once I found a truly supportive environment, I was able to not only start numerous companies on my heart research, but commercialize my over 25 years of University research into medical devices now in over 30,000 patients with no implant failures. No infection. No chronic inflammation. No implant loosening. No failures. No cancer. Better human health, including the heart, undoubtedly.

So I encourage everyone to find that right environment. Attend HEART CONGRESS 2025 at the heart of innovation and commercialization! Meet the right people! Be energized by optimistic people! At HEART CONGRESS 2025, we will not only discuss the next heart research breakthroughs, but more importantly, we will discuss how to commercialize it!

I look forward to seeing everyone!

Heart Congress 2025 | Rome, Italy | Hybrid Event

It is our genuine pleasure to invite you to attend 3rd Edition of International Heart Congress in the Great Rome, Italy, to be held on June 05 -07, 2025.

This event features opportunities to make network with colleagues and partners from the Globe in an exciting environment. The scope and quality of the scientific exchange makes this Conference the elite cardiovascular research and instructional meeting in the World. The Conference is to provide an innovative and comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of personalized cardiology and preventive cardiac surgery. The major goal will be to demonstrate recent development in prevention and prophylaxis, cardiovascular risk prediction based on risk assessment procedures. The impact of the latest cardiac biomarker-based platforms to illustrate and to monitor subclinical and/or clinical atherosclerosis, myocarditis, aortic and arterial diseases will be discussed.

The Conference would feature three fantastic days of the best in cardiovascular clinical practice and scientific content covering interdisciplinary aspects of basic, clinical, applied and translational applications. So, medical doctors, scientists, biodesigners and bioengineers, health professionals and healthcare givers will come together in order to obtain and exchange information on advances in the management of chronic cardiac disorders being controlled via applications of canonical therapeutic and newest preventive, prophylactic and rehabilitative manipulations. The Conference will also provide a unique opportunity for Pharma to exhibit their new products and to contact with the cardiologists more closely. Participants will have the opportunities to share information and the latest advance in cardiology to renew the friendship, and to increase worldwide collaboration.

We are most pleased to invite you to participate in this Meeting, which will feature several sessions and invited lectures on the basic research and translational applications of heart disease. This Conference will be of great value to interns, residents, postdocs and fellows of Cardiology as well as cardiovascular scientists, biodesigners and biotechnologists, academic cardiologists and practicing physicians. It will be a learning experience regarding the role of Personalized & Precision Cardiology in improving the therapy of cardiovascular disease.

We do hope that you will enjoy the Congress and that your interaction with your colleagues will stimulate a creative exchange of ideas and will be personally rewarding!

2nd Edition of International Heart Congress | Paris, France

In my capacity as a Member of the Scientific Committee of Heart Congress 2024 to be held in Paris, France during August 13-14, 2024, I am most pleased to invite you to participate in this Cardiology meeting, which will feature several sessions and invited lectures on the pathophysiology and pharmacotherapy of heart disease. Particularly, this conference will focus on new developments in the area of ischemic heart disease, heart failure, cardiac remodeling, arrhythmias, cardiomyopathies and metabolic syndrome. This conference will be of great value to Interns, Residents and Fellows of Cardiology as well as cardiovascular scientists, academic cardiologists and practicing physicians. It will be a learning experience regarding the role of translational medicine in improving the therapy of cardiovascular disease.

Heart Congress 2024 | Paris, France and Online

Dear congress visitor it is an honor and a pleasure to write a few welcome notes. Disturbance of microcirculation in the musculoskeletal system is a prime cause of pain and injury. It has been shown that chronic muscle spasm impedes skeletal muscle microcirculation and results in loss of mitochondria and muscle fibers. It has been further shown that resolution of the chronic muscle spasm allows the muscle to regenerate mitochondria and muscle fibers. Disturbances of microcirculation appear to also play a role in the development of tendinopathy. The microcirculation of tendons is easily impaired by chronic tension cause by chronic spasm of the attached muscles. I will share with you the findings of my clinical research over the past 15 years and the theories that developed to explain those findings.

Heart Congress | Paris, France

Dear Congress Visitors,

I am delighted to welcome you to the International Heart Congress. Clearly, the heart is one of the most important organs in our body. However, it is also one of the most problematic organs in the body. According to the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death globally with an estimated 17.9 million people who died from CVDs in 2019. Of course, with COVID following shortly thereafter, such statistics (including a drop in global life expectancy) have only become worse. Alarmingly, CVDs represent 32% of all global deaths. If our efforts over the last century have helped prevent, diagnose, and treat CVDs (which I think they have), why are so many people still dying from CVDs ? Are our approaches focused correctly ? At the right people ? At the right communities ? Let me give you my thoughts.

While it is true that many traditional societal conferences have been devoted to CVDs, this congress is different. This International Heart Congress has contributions from all over the world, fit for all over the world. I personally am always disappointed to see the same presentations from the same people at well-established societies or conferences – it is truly the “all boys network”, usually from wealthy countries receiving grants from funding agencies that prohibit reaching a truly global population. While such research is important, such talks are usually not focused on CVD solutions that can benefit the entire world. Did you know that, as true with other diseases, those from under-developed countries suffer CVDs the most accounting for over 75% of the total CVD deaths globally ? We have to transition our thinking to helping everyone, not just the country we are from – only then will we see global decreases in CVD. We need to ask ourselves the following questions: Does our research address CVD healthcare to those with limited sources ? Geographical restrictions ? No healthcare at all ? How can we be solving CVDs without reaching the patients that need them most ? What can you do ? This is why I personally have committed to this fight and established a new research fund for Nigeria and other African countries to explore the best healthcare options for CVDs.

These and other new ground-breaking issues in global CVDs will be discussed at this International Heart Congress. Join me in developing new strategies to prevent, diagnose, and treat CVDs for everyone. Set your goal that can help once and for all make CVDs a statistic from the past, not the present, and certainly not the future. Set your goal to reduce CVDs where 75% of all CVDs occur, only then, can we see a change in CVD statistics.

Let’s get going

Heart Congress | Paris, France and Online

We are gathering for the Second International Heart Conference organized by the Magnus Group, initially held last year in Tokyo. You will enjoy and be educated by incisive talks on coronary heart disease, heart failure and dysrhythmia over three days in the heart of France, presented by an inspired group of international speakers. Your experience will include both up to date reviews in how to understand and manage routine heart disease problems in everyday clinical practice, as well as being informed about the current efforts in research to provide better outcomes and lower cost for our patients with heart disease.

In short, you will have a wonderful time here with us, while learning from an ecletic group of experts who bring different opinions toward the management of heart disease based on their own clinical experience from around the world. This approach provides you with an opportunity to easily ask questions pertinent to your own problems in providing cardiac care in your own venue. The faculty is primed to discuss your questions in detail.

Thanks for coming and enjoy Paris!

Heart Congress 2024

Dear congress visitors, it is an honor and pleasure to write a few welcome notes in regard to the forthcoming”2^nd Edition of International Heart Congress”. Clinically acceptable and cost-effective patient care represents an ultimate goal of the state-of-the-art cardiology investigations, further supported by innovative technologies and fast approaching artificial intelligence. Treating heart failure and related cardiovascular diseases are excellent starting points to gather distinguished scientists and healthcare professionals to discuss groundbreaking advancements, as well as clinical challenges, in order to find some evidence-based and novel directions to improve our knowledge in this field. This event will without any doubt foster further cooperation and sharing new results

2nd Edition of International Heart Congress | Hybrid Event

Dear Congress Visitors:

As the Congress Organizing Committee Member and Keynote Speaker, I am very honored and pleased to write these welcome notes.

The current congress, Heart Congress 2024, aims to address the global challenge posed by cardiovascular disease, a leading cause of approximately 15 million annual fatalities worldwide.

Clearly, the upcoming Heart Congress 2024 will bring together leading researchers, scientists, clinicians, and industry professionals from cardiovascular health and disease fields around the world. The congress will include outstanding keynote sessions, plenary lectures, invited speeches, research presentations, technical demonstrations, and panel discussions around the world.

All the planned latest cutting-edge presentations and demonstrations will highlight the recent past, current, and future cardiology research, explore innovative technologies in heart disease treatment, and shed light on advancements in managing cardiovascular diseases. Furthermore, these presentations and demonstration will also energize innovative developments and discoveries to unveil breakthroughs and shape future various objectives.

I am very excited to look forward to meeting with you at this upcoming fantastic congress.

Delve into a transformative experience encapsulated by the theme "HEART: Holistic Efforts in Advancing Research and Treatment for Cardiovascular Well-being." The event

Participants can anticipate a dynamic exchange of insights, where they can share their latest research findings and gain valuable perspectives from diverse corners of the globe. The event seeks to accelerate breakthroughs in science, trials, and innovations within the realm of cardiology.

Heart Congress 2024 is an annual collaboration that brings together members of the organizing committee and prominent personalities in the field of cardiology. It serves as a platform for discovering the latest knowledge and innovations shaping the future of cardiovascular health.

2nd Edition of International Heart Congress | June 20-22,2024

As  a  member  of the  Scientific  committee , it is  my  utmost  pleasure  to  welcome  you all to HEART CONGRESS 2024. This is a three days hybrid event happening on 20th- 22nd June 2024. The  live  event   will  take  place  in the  beautiful  city of  Paris , France  but you  also  have the  opportunity  to  attend  virtually  if you  are  unable  to  make it  physically. This  scientific  feast  is  going  to  witness high  calibre  key  note  speakers  and experts from  different  parts  of  the  world who  will  present  and discuss  a  wide  range  of  key topics in  cardiovascular  Medicine. There will be ample discussion on latest guidelines, innovations  and  research  in Cardiology  which  will  be  so  beneficial  to  enrich  your knowledge and  skills in this  rapidly  changing field of  Medicine.

I am looking forward to your active participation.

Heart Congress 2024 | Hybrid Event

Dear colleagues and congress visitors. Let me welcome you. The Congress has an important mission, presenting the latest advances in cardiology and expert opinions. The scientific program includes reports from around the world, which gives international status to this scientific event. The exchange of experience and education of practicing doctors is the advantage of this congress. The hybrid mode allows specialists from different parts of the world to participate. I wish success to the organizers and participants of Heart Congress 2024.

International Heart Congress, May 24 - 25, 2023 | Tokyo, Japan | Hybrid Event

Dear congress visitors, speakers and chairs, it is an honor and pleasure to participate in this prestigious event. The field of cardiovascular and heart research is fastly growing with many innovations being discovered along the way. Other promising ideas and hypothesis are being discussed and tested among our courageous researchers. This opens new opportunities to better detect, treat, and manage heart and cardiovascular diseases, with the hope that in the future curative approaches will be discovered. The theme of our conference this year is ” Advances in Cardiology: Research and Innovations”. The Conference will provide an opportunity for participants to present their work and provide an updated on areas related to both theoretical and applied research in the field of heart and cardiovascular research. Furthermore, the Conference will provide a nourishing environment for visitors to exchange idea, knowledge, information, learn new things and possibly build new collaborations based on the common interested between them. For the International Heart Congress 2023 I would be very glad if we could reach a record number of participants, presentations and if this conference would lead to the establishment of fruitful interactions among participants and new cultural proposals that can grow up for the positive development of the Conference and for the intellectual growth of all the participants. Finally, I would like to thank all the participants, visitors and a special thanks goes to the organizing Committee and everyone who helped facilitate this conference for the tremendous human effort they made.

International Heart Congress, May 24 - 25, 2023 | Tokyo, Japan.

As a member of the organizing committee, it is my absolute pleasure to welcome you all to the much-awaited scientific feast ‘Heart Congress 2023’ to be held in the beautiful city of Tokyo, Japan.

Cardiovascular Medicine is the most paced field of Medicine with innovative research and cutting technology. You will have an opportunity to listen to keynote speakers and world-renowned experts in the field of Cardiovascular Medicine. There will keynote lectures, plenary scientific sessions and posters. I can assure you 2 days of a high-class learning experience blended with professional networking as well as plenty of time to explore city of historical culture and mouth-watering cuisine.

The conference organizers are working hard to put together a conference worth remembering.

I personally cannot wait to see you all in May 2023.

3rd Edition of Cardiology World Conference | Paris, France, September 14 -15, 2022

Dear colleagues!

The problem of the development of cardiology lies in the development of new knowledge. In my report, I will introduce you to a new paradigm of knowledge that has already become part of widespread practice. The name of new science – CARDIOMETRY. With the help of only an ECG, it is possible to accurately and quickly diagnose all types of changes in the cardiovascular system, including metabolic processes in the cardiac muscles, as well as the connection of the heart with the central nervous system. In our journal on https://www.cardiometry.net/  you can find a lot of interesting materials that will help you in your work.

3rd Edition of Cardiology World Conference, September 14 -15, 2022 | Paris, France

Dear participants of the World Conference on Cardiology.

Cardiovascular disease continues to lead the way in complications and deaths among adults around the world. In developed countries, the incidence rate has decreased, while in developing countries, these rates are somewhat different. Numerous international studies are being carried out to improve the diagnosis, treatment and, most importantly, the prevention of cardiovascular diseases. As data accumulates, international recommendations are updated. It is safe to say that international treatment standards are applied in all countries. But there is a lot of work to be done to introduce innovative technologies in cardiology.

I believe that scientific and educational conferences with the exchange of opinions of specialists from different countries are positively reflected  in the accumulation of experience in the fight against cardiovascular diseases.

I call on my colleagues to actively participate in the work of the World Conference on Cardiology 2022 and wish you success.

Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan

One of the themes of this conference is that of myocardial ischaemia and infarction. At first glance, this would seem to represent purely a repetition of our previous focus on the traditional theme of a common spectrum of cardiovascular disorders driven by the traditional risk factors of hypertension, smoking, diabetes and poor diet, and emerging mainly in middle-aged men. Our therapeutic discussion 30 years ago would have emphasised coronary revascularization above all. However, much has changed. In Western societies, emergence of coronary atheroma-related disease has generally been delayed, if not prevented, while an emerging epidemic threatens the Third World. We have finally learned the importance of inflammation as a key component of the pathogenesis of atherogenesis and myocardial Welcome Message ischaemia, and are beginning to refine our pharmacotherapy to accommodate the recognition of its potential effectiveness and the emergence of “new” forms of acute heart disease which occur mainly in women. I welcome you to the ischaemia/infarction section of the Conference, and trust that you will find our discussions exciting and providing of a better guide to future treatment.

Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan

Dear conference participants and colleagues, I am glad to welcome you to the international conference on cardiology. Cardiovascular diseases are still the main cause of complications and mortality in adults. Moreover, this global trend is observed in both developed and developing countries of the world. Conducted international clinical studies to identify risk factors, primary and secondary prevention of cardiovascular diseases. Annually, the results of major projects on the effectiveness of drugs and new technologies are published. In the 21st century, digital technologies are increasingly used in cardiology. The international conference will highlight various areas in cardiology, which will help in the practical work of specialists. I wish you fruitful work.

Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan

Dear congress visitors, It gives me great pleasure to write a few welcome notes. The field of cardiovascular biomarker research is entering a new, exciting era with the introduction of the concept of ‘personalized medicine’ in therapeutic treatment guidance. With a variety of new cardiovascular biomarkers, and assertions of their respective independent associations with outcome, it becomes increasingly difficult to select the biomarker with the strongest diagnostic as well as prognostic value. One can expect that the increasing use of cardiovascular biomarkers, accompanying traditional diagnostic and prognostic measures, for specific cardiovascular diseases, will lead to their almost crucial role in clinical decision making. However, the search for an ideal biomarker, or set of biomarkers, requires a systematic and rigorous approach to biomarker studies, more emphasis on Welcome Message prospective studies, and use of external validation cohorts. Accomplishment of the previous will lead to improved quality of diagnostic and, even more important, prognostic biomarker research in the future, and will be required if we want to bring this clinically important research field forward.

Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan

Dear congress participants, it is an honor and pleasure to write a few welcome notes. During the last decade, research in cardiovascular field has dramatically increased leading to a substantial improvement in the treatment and the outcome of patients affected with cardiovascular diseases. The main theme of the “Cardiology World Conference” (CWC 2019) will be the “Advances in Cardiology: Research and Innovations”. Latest breaking trials, innovations and hot topics will be discussed in depth during the event involving different fields and specialties contributing to cardiovascular research. Hence, we strongly believe that CWC 2019 will represent a major platform for promoting and advancing cardiology in its dynamic field. We look forward to welcoming you in Tokyo (Japan), for what promises to be an unforgettable Conference. See you there!